Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_assertion type Assertion NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_head.
- NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_assertion wasGeneratedBy ECO_0000203 NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_provenance.
- NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_assertion wasDerivedFrom befree-20150227 NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_provenance.
- NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_assertion SIO_000772 23894143 NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_provenance.
- NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_assertion evidence source_evidence_literature NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_provenance.
- NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_assertion description "[These findings uncover a novel mechanism of erlotinib resistance and provide a novel approach to overcome resistance by blocking the STAT3/Bcl2/Bcl-XL survival signaling pathway in human lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264533.RA8bV2tATQLpk_5n3ir-WU_0MIflFiOZgaIveF5-6PbBc130_provenance.